Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 11 May 2009 |
| Ofatumumab and R1507 Data to be Presented at ASCO | 11 May 2009 |
| FDA Advisory Committee to Review Arzerra(TM) (Ofatumumab) | 4 May 2009 |
| Articles of Association of Genmab A/S dated April 15, 2009 | 28 Apr 2009 |
| Passing of Genmab A/S' Annual General Meeting | 15 Apr 2009 |